Fingerprint
Dive into the research topics of 'Clinical safety of the selective PKC-β inhibitor, ruboxistaurin'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Clinical safety of the selective PKC-β inhibitor, ruboxistaurin
Janet B. McGill, George L. King, Paul H. Berg, Karen L. Price, Keri A. Kles, Edward J. Bastyr, David L. Hyslop
Research output: Contribution to journal › Review article › peer-review
41
Scopus
citations